FDA approves gene therapy Luxturna for hereditary blindness FDA approves gene ther Wednesday December 20th, 2017By Tokio X'press FDA, Statistics, Pharmaceutical Pfizer, Luxturna, ONO FDA approves gene ther
💊FDA PHARMA today 💊FDA PHARMA to Tuesday December 19th, 2017By Tokio X'press offices, FDA, Pharmaceutical ONO 💊FDA PHARMA to
💊Merck’s Keytruda Misses Primary End Point for Gastric Cancer 💊Merck’s Saturday December 16th, 2017By Tokio X'press FDA, Pharmaceutical Merck's 💊Merck’s
🏹Zacks Investment Research today 🏹Zacks Investm Friday December 15th, 2017By Tokio X'press FDA, Pharmaceutical Pfizer 🏹Zacks Investm
💊FDA PHARMA today 💊FDA PHARMA to Thursday December 14th, 2017By Tokio X'press FDA, Pharmaceutical Bristol-Myers Squibb, Pfizer, Bayer 💊FDA PHARMA to
